Development of transcriptionally regulated oncolytic adenoviruses

Oncogene

Volumn 24, Issue 52, 2005, Pages 7763-7774

  Ko, Derek ^a   Hawkins, Lynda ^a,b   Yu, De Chao ^a  

^a CELL GENESYS INC   (United States)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VACCINE; ADENOVIRUS VECTOR; ANGIOGENESIS INHIBITOR; ANTIBODY CONJUGATE; ANTINEOPLASTIC AGENT; CANCER VACCINE; CG 0070; CG 7060; CISPLATIN; CV 711; CV 757; CV 764; CV 771; CV 787; CV 840; CV 890; CYTOKINE; CYTOLYSIN; CYTOSINE DEAMINASE; DIPEPTIDYL CARBOXYPEPTIDASE; DOCETAXEL; FLUOROURACIL; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOSTIMULATING AGENT; NITROREDUCTASE; OAS 403; ONCOLYTIC VIRUS; ONYX 015; ONYX 411; THYMIDINE KINASE; UNCLASSIFIED DRUG; VIRUS VACCINE; VRX 009;

ADENOVIRUS; ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; CANCER INHIBITION; CHILL; CLINICAL TRIAL; COLON TUMOR; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENCY; DRUG POTENTIATION; DRUG SAFETY; DRUG TOLERABILITY; FEVER; FLU LIKE SYNDROME; HEMATURIA; HUMAN; INJECTION SITE PAIN; LIVER FUNCTION TEST; LIVER TUMOR; MALIGNANT TRANSFORMATION; MAXIMUM TOLERATED DOSE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; REVIEW; SIDE EFFECT; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION; TRANSGENE; TUMOR; URINARY TRACT DISEASE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIROGENESIS; VIRUS INFECTION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ADENOVIRIDAE; CELL TRANSFORMATION, NEOPLASTIC; COMBINED MODALITY THERAPY; GENE THERAPY; GENETIC VECTORS; HUMANS; NEOPLASMS; ONCOLYTIC VIROTHERAPY; ONCOLYTIC VIRUSES; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC; TRANSGENES; VIRUS REPLICATION;

ADENOVIRIDAE; ONYX;

EID: 27944471015     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209048     Document Type: Review

References (82)

1. Adams PD and Kaelin Jr WG. (1995). Semin. Cancer Biol., 6, 99-108.
2. Aghi M and Martuza RL. (2005). Oncogene, 24, 7802-7816.
3. Barker DD and Berk AJ. (1987). Virology, 156, 107-121.
4. Bell JA, Ward TG, Huebner RJ, Rowe WP, Suskind RG and Paffenbarger RS. (1956). Am. J. Public Health, 46, 1130-1146.
5. Berget SM, Moore C and Sharp PA. (1977). Proc. Natl. Acad. Sci. USA, 74, 3171-3175.
6. Berk AJ, Lee F, Harrison T, Williams J and Sharp PA. (1979). Cell, 17, 935-944.
7. Berk AJ and Sharp PA. (1978). Cell, 14, 695-711.
8. Berk AJ. (2005). Oncogene, 24, 7673-7685.
9. Bett AJ, Prevec L and Graham FL. (1993). J. Virol., 67, 5911-5921.
10. Bienz M and Clevers H. (2000). Cell, 103, 311-320.
11. Bischoff JR, Kirn DH, Williams A, Heise C, Horn S, Muna M, Ng L, Nye JA, Sampson-Johannes A, Fattaey A and McCormick F. (1996). Science, 274, 373-376.
12. Bristol JA, Zhu M, Ji H, Mina M, Xie Y, Clarke L, Forry-Schaudies S and Ennist DL. (2003). Mol. Ther., 7, 755-764.
13. Chen Y, DeWeese T, Dilley J, Zhang Y, Li Y, Ramesh N, Lee J, Pennathur-Das R, Radzyminski J, Wypych J, Brignetti D, Scott S, Stephens J, Karpf DB, Henderson DR and Yu DC. (2001). Cancer Res., 61, 5453-5460.
14. Cripe TP, Dunphy EJ, Holub AD, Saini A, Vasi NH, Mahller YY, Collins MH, Snyder JD, Krasnykh V, Curiel DT, Wickham TJ, DeGregori J, Bergelson JM and Currier MA. (2001). Cancer Res., 61, 2953-2960.
15. DeWeese T, Arterbery E, Michalski J, Sylvester JE, Terris MK, Wilding G, Yu DC, Moore L, Kimball L, Ando D and Kirn D. (2003). Mol. Ther., 7 (Suppl. 1): Abstract 1158.
16. DeWeese TL, van der Poel H, Li S, Mikhak B, Drew R, Goemann M, Hamper U, DeJong R, Detorie N, Rodriguez R, Haulk T, DeMarzo AM, Piantadosi S, Yu DC, Chen Y, Henderson DR, Carducci MA, Nelson WG and Simons JW. (2001). Cancer Res., 61, 7464-7472.
17. Dilley J, Reddy P, Ko D, Nguyen N, Rojas V, Working P and Yu DC. (2005). Cancer Gene Ther., 12, 715-722.
18. Dmitriev I, Krasnykh V, Miller CR, Wang M, Kashentseva E, Mikheeva G, Belousova N and Curiel DT. (1998). J. Virol., 72, 9706-9713.
19. Dobbelstein M, Roth J, Kimberly WT, Levine AJ and Shenk T. (1997). EMBO J., 16, 4276-4284.
20. Douglas JT, Kim M, Sumerel LA, Carey DE and Curiel DT. (2001). Cancer Res., 61, 813-817.
21. Fisher KD, Stallwood Y, Green NK, Ulbrich K, Mautner V and Seymour LW. (2001). Gene Therapy, 8, 341-348.
22. Freytag SO, Khil M, Stricker H, Peabody J, Menon M, DePeralta-Venturina M, Nafziger D, Pegg J, Paielli D, Brown S, Barton K, Lu M, Aguilar-Cordova E and Kim JH. (2002). Cancer Res., 62, 4968-4976.
23. Freytag SO, Stricker H, Pegg J, Paielli D, Pradhan DG, Peabody J, DePeralta-Venturina M, Xia X, Brown S, Lu M and Kim JH. (2003). Cancer Res., 63, 7497-7506.
24. Giedlin MA, Cook DN and Dubensky Jr TW. (2003). Cancer Cell, 4, 241-243.
25. Gooding LR, Elmore LW, Tollefson AE, Brady HA and Wold WS. (1988). Cell, 53, 341-346.
26. Gooding LR, Ranheim TS, Tollefson AE, Aquino L, Duerksen-Hughes P, Horton TM and Wold WS. (1991). J. Virol., 65, 4114-4123.
27. Green NK, Herbert CW, Hale SJ, Hale AB, Mautner V, Harkins R, Hermiston T, Ulbrich K, Fisher KD and Seymour LW. (2004). Gene Therapy, 11, 1256-1263.
28. Han J, Modha D and White E. (1998). Oncogene, 17, 2993-3005.
29. Hemminki A, Dmitriev I, Liu B, Desmond RA, Alemany R and Curiel DT. (2001). Cancer Res., 61, 6377-6381.
30. Henderson D and Yu D. (2002). Adenoviral Vectors for Gene Therapy. Curiel D and Douglas J (eds). Academic Press: San Diego, CA, pp 287-319.
31. Henttu P, Liao SS and Vihko P. (1992). Endocrinology, 130, 766-772.
32. Hermiston TW, Tripp RA, Sparer T, Gooding LR and Wold WS. (1993). J. Virol., 67, 5289-5298.
33. Hitt MM and Graham FL. (1990). Virology, 179, 667-678.
34. Hoffmann D, Jogler C and Wildner O. (2005). J. Gene Med., June 9 [E-pub ahead of print].
35. Huneycutt BS, Bi Z, Aoki CJ and Reiss CS. (1993). J. Virol., 67, 6698-6706.
36. Ikeda MA and Nevins JR. (1993). Mol. Cell Biol., 13, 7029-7035.
37. Ilan Y, Droguett G, Chowdhury NR, Li Y, Sengupta K, Thummala NR, Davidson A, Chowdhury JR and Horwitz MS. (1997). Proc. Natl. Acad. Sci. USA, 94, 2587-2592.
38. Jakubczak JL, Ryan P, Gorziglia M, Clarke L, Hawkins LK, Hay C, Huang Y, Kaloss M, Marinov A, Phipps S, Pinkstaff A, Shirley P, Skripchenko Y, Stewart D, Forry-Schaudies S and Hallenbeck PL. (2003). Cancer Res., 63, 1490-1499.
39. Jenkins JR, Rudge K and Currie GA. (1984). Nature, 312, 651-654.
40. Johnson L, Shen A, Boyle L, Kunich J, Pandey K, Lemmon M, Hermiston T, Giedlin M, McCormick F and Fattaey A. (2002). Cancer Cell, 1, 325-337.
41. Khuri FR, Nemunaitis J, Ganly I, Arseneau J, Tannock IF, Romel L, Gore M, Ironside J, MacDougall RH, Heise C, Randlev B, Gillenwater AM, Bruso P, Kaye SB, Hong WK and Kirn DH. (2000). Nat. Med., 6, 879-885.
42. Kirn D. (2000). Oncogene, 19, 6660-6669.
43. Krajcsi P and Wold WS. (1992). Virology, 187, 492-498.
44. Li Y, Yu DC, Chen Y, Amin P, Zhang H, Nguyen N and Henderson DR. (2001). Cancer Res., 61, 6428-6436.
45. Lichtenstein DL, Doronin K, Toth K, Kuppuswamy M, Wold WS and Tollefson AE. (2004). J. Virol., 78, 12297-12307.
46. Lichtenstein DL, Krajcsi P, Esteban DJ, Tollefson AE and Wold WS. (2002). J. Virol., 76, 11329-11342.
47. Lipinski KS, Djeha AH, Ismail T, Mountain A, Young LS and Wrighton CJ. (2001). Mol. Ther., 4, 365-371.
48. Lukas J, Muller H, Bartkova J, Spitkovsky D, Kjerulff AA, Jansen-Durr P, Strauss M and Bartek J. (1994). J. Cell Biol., 125, 625-638.
49. Mitsui Y, Hanabusa J, Minoda R and Ogata S. (1957). Am. J. Ophthalmol., 43, 84-90.
50. Nevins JR. (1981). Cell, 26 (2 Part 2), 213-220.
51. Obert S, O'Connor RJ, Schmid S and Hearing P. (1994). Mol. Cell Biol., 14, 1333-1346.
52. Osborne TF and Berk AJ. (1983). J. Virol., 45, 594-599.
53. O'Shea C, Klupsch K, Choi S, Bagus B, Soria C, Shen J, McCormick F and Stokoe D. (2005). EMBO J., 24, 1211-1221.
54. O'Shea CC, Johnson L, Bagus B, Choi S, Nicholas C, Shen A, Boyle L, Pandey K, Soria C, Kunich J, Shen Y, Habets G, Ginzinger D and McCormick F. (2004). Cancer Cell, 6, 611-623.
55. Parr MJ, Manome Y, Tanaka T, Wen P, Kufe DW, Kaelin Jr WG and Fine HA. (1997). Nat. Med., 3, 1145-1149.
56. Polakis P. (2000). Genes Dev., 14, 1837-1851.
57. Ramesh N, Ge Y, Ennist DL, Zh M, Mina M, Ganesh S, Reddy PS and Yu D-C. (2005). Clin. Cancer Res., (submitted).
58. Rao L, Debbas M, Sabbatini P, Hockenbery D, Korsmeyer S and White E. (1992). Proc. Natl. Acad. Sci. USA, 89, 7742-7746.
59. Reid T, Warren R and Kirn D. (2002). Cancer Gene. Ther., 9, 979-986.
60. Rodriguez R, Schuur ER, Lim HY, Henderson GA, Simons JW and Henderson DR. (1997). Cancer Res., 57, 2559-2563.
61. Rubinchik S, Lowe S, Jia Z, Norris J and Dong J. (2001). Gene Therapy, 8, 247-253.
62. Ryan PC, Jakubczak JL, Stewart DA, Hawkins LK, Cheng C, Clarke LM, Ganesh S, Hay C, Huang Y, Kaloss M, Marinov A, Phipps SS, Reddy PS, Shirley PS, Skripchenko Y, Xu L, Yang J, Forry-Schaudies S and Hallenbeck PL. (2004). Cancer Gene Ther., 11, 555-569.
63. Sarnow P, Ho YS, Williams J and Levine AJ. (1982). Cell, 28, 387-394.
64. Schuur ER, Henderson GA, Kmetec LA, Miller JD, Lamparski HG and Henderson DR. (1996). J. Biol. Chem., 271, 7043-7051.
65. Sellers WR, Rodgers JW and Kaelin Jr WG. (1995). Proc. Natl. Acad. Sci. USA, 92, 11544-11548.
66. Shayakhmetov DM, Eberly AM, Li ZY and Lieber A. (2005). J. Virol., 79, 1053-1061.
67. Shen Y. (2003). Homologous Recombination of Onyx-411 and Analyses of the Recombination Products. Twelfth International Conference on Gene Therapy of Cancer. International Society of Cancer Gene Therapy (Conference Organizer): San Diego, Abstract 47.
68. Small EM, Carducci G, Wilding D-C and Yu DA. (2002). 5th Annual Meeting Of American Scoiety Of Gene Therapy (June 5-9, Boston), Abstract 52.
69. Stojdl DF, Abraham N, Knowles S, Marius R, Brasey A, Lichty BD, Brown EG, Sonenberg N and Bell JC. (2000). J. Virol., 74, 9580-9585.
70. Tollefson AE, Scaria A, Hermiston TW, Ryerse JS, Wold LJ and Wold WS. (1996). J. Virol., 70, 2296-2306.
71. Toth K, Djeha H, Ying B, Tollefson AE, Kuppuswamy M, Doronin K, Krajcsi P, Lipinski K, Wrighton CJ and Wold WS. (2004). Cancer Res., 64, 3638-3644.
72. Varghese S and Rabkin SD. (2002). Cancer Gene Ther., 9, 967-978.
73. Wakimoto H, Johnson PR, Knipe DM and Chiocca EA. (2003). Gene Therapy, 10, 983-990.
74. Ward TG, Huebner RJ, Rowe WP, Ryan RW and Bell JA. (1955). Science, 122, 1086-1087.
75. Worgall S, Wolff G, Falck-Pedersen E and Crystal RG. (1997). Hum. Gene Ther., 8, 37-44.
76. Yew PR and Berk AJ. (1992). Nature, 357, 82-85.
77. Young CY, Andrews PE, Montgomery BT and Tindall DJ. (1992). Biochemistry, 31, 818-824.
78. Young CY, Montgomery BT, Andrews PE, Qui SD, Bilhartz DL and Tindall DJ. (1991). Cancer Res., 51, 3748-3752.
79. Yu DC, Chen Y, Dilley J, Li Y, Embry M, Zhang H, Nguyen N, Amin P, Oh J and Henderson DR. (2001). Cancer Res., 61, 517-525.
80. Yu DC, Chen Y, Seng M, Dilley J and Henderson DR. (1999a). Cancer Res., 59, 4200-4203. Erratum in: Cancer Res 2000 Feb 15; 60: 1150.
81. Yu DC, Sakamoto GT and Henderson DR. (1999b). Cancer Res., 59, 1498-1504.
82. Zhu M, Bristol JA, Xie Y, Mina M, Ji H, Forry-Schaudies S and Ennist DL. (2005). J. Virol., 79, 5455-5465.